These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31582580)

  • 1. The simplified oral flucloxacillin absorption test: an accurate method to identify patients with inadequate oral flucloxacillin absorption.
    Dijkmans AC; Kweekel DM; Balmforth C; van Esdonk MJ; van Dissel JT; Burggraaf J; Kamerling IMC
    Neth J Med; 2019 Sep; 77(7):255-260. PubMed ID: 31582580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simplified oral flucloxacillin absorption test for patients requiring long-term treatment.
    Dijkmans AC; Hartigh Jd; van Dissel JT; Burggraaf J
    Ther Drug Monit; 2012 Jun; 34(3):356-8. PubMed ID: 22569354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetic modelling of total and unbound flucloxacillin in non-critically ill patients to devise a rational continuous dosing regimen.
    Wilkes S; van Berlo I; Ten Oever J; Jansman F; Ter Heine R
    Int J Antimicrob Agents; 2019 Mar; 53(3):310-317. PubMed ID: 30472288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total flucloxacillin plasma concentrations poorly reflect unbound concentrations in hospitalized patients with Staphylococcus aureus bacteraemia.
    Chin PKL; Drennan PG; Gardiner SJ; Zhang M; Dalton SC; Chambers ST; Begg EJ
    Br J Clin Pharmacol; 2018 Oct; 84(10):2311-2316. PubMed ID: 29908071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis.
    Leder K; Turnidge JD; Korman TM; Grayson ML
    J Antimicrob Chemother; 1999 Jan; 43(1):113-8. PubMed ID: 10381108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone penetration of intravenous flucloxacillin and gentamicin as antibiotic prophylaxis during total hip and knee arthroplasty.
    Torkington MS; Davison MJ; Wheelwright EF; Jenkins PJ; Anthony I; Lovering AM; Blyth M; Jones B
    Bone Joint J; 2017 Mar; 99-B(3):358-364. PubMed ID: 28249976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flucloxacillin dosing in critically ill patients with hypoalbuminaemia: special emphasis on unbound pharmacokinetics.
    Ulldemolins M; Roberts JA; Wallis SC; Rello J; Lipman J
    J Antimicrob Chemother; 2010 Aug; 65(8):1771-8. PubMed ID: 20530507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics and dosing of flucloxacillin in preterm and term neonates.
    Pullen J; de Rozario L; Stolk LM; Degraeuwe PL; van Tiel FH; Zimmermann LJ
    Ther Drug Monit; 2006 Jun; 28(3):351-8. PubMed ID: 16778719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low flucloxacillin concentrations in a patient with central nervous system infection: the need for plasma and cerebrospinal fluid drug monitoring in the ICU.
    Abdul-Aziz MH; McDonald C; McWhinney B; Ungerer JP; Lipman J; Roberts JA
    Ann Pharmacother; 2014 Oct; 48(10):1380-4. PubMed ID: 24951308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In healthy volunteers, taking flucloxacillin with food does not compromise effective plasma concentrations in most circumstances.
    Gardiner SJ; Drennan PG; Begg R; Zhang M; Green JK; Isenman HL; Everts RJ; Chambers ST; Begg EJ
    PLoS One; 2018; 13(7):e0199370. PubMed ID: 30001392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of pharmacological target attainment with flucloxacillin and cefazolin in invasive methicillin-susceptible Staphylococcus aureus infection: a prospective cohort study in hospitalized patients.
    Campbell PO; Chin PKL; Dalton SC; Metcalf SCL; Douglas NM; Chambers ST
    Int J Antimicrob Agents; 2023 Jan; 61(1):106695. PubMed ID: 36464153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of linezolid, flucloxacillin and vancomycin in the empirical treatment of cellulitis in UK hospitals: a decision analytical model.
    Vinken A; Li Z; Balan D; Rittenhouse B; Wilike R; Nathwani D
    J Hosp Infect; 2001 Dec; 49 Suppl A():S13-24. PubMed ID: 11926436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flucloxacillin does not achieve therapeutic cerebrospinal fluid levels against meticillin-sensitive Staphylococcus aureus in adults: A case report and review of the literature.
    Chew R; Woods ML
    Int J Antimicrob Agents; 2016 Mar; 47(3):229-31. PubMed ID: 26915477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetics at two dose levels and pharmacodynamic profiling of flucloxacillin.
    Landersdorfer CB; Kirkpatrick CM; Kinzig-Schippers M; Bulitta JB; Holzgrabe U; Drusano GL; Sörgel F
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3290-7. PubMed ID: 17576847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring of flucloxacillin.
    van Daele PLA
    Neth J Med; 2019 Sep; 77(7):233. PubMed ID: 31582583
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics and bioavailability of flucloxacillin in elderly hospitalized patients.
    Gath J; Charles B; Sampson J; Smithurst B
    J Clin Pharmacol; 1995 Jan; 35(1):31-6. PubMed ID: 7751411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of antibiotic treatment of implant-associated
    Greimel F; Scheuerer C; Gessner A; Simon M; Kalteis T; Grifka J; Benditz A; Springorum HR; Schaumburger J
    Drug Des Devel Ther; 2017; 11():1729-1736. PubMed ID: 28652709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration.
    Røder BL; Frimodt-Møller N; Espersen F; Rasmussen SN
    Infection; 1995; 23(2):107-12. PubMed ID: 7622258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe Disseminated Infection with Emerging Lineage of Methicillin-Sensitive Staphylococcus aureus.
    Jewell P; Dixon L; Singanayagam A; Ghani R; Wong E; Coleman M; Pichon B; Kearns A; Russell G; Hatcher J
    Emerg Infect Dis; 2019 Jan; 25(1):187-189. PubMed ID: 30561304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond Penicillin: Rapid Desensitization for Specific Flucloxacillin Hypersensitivity.
    Kwong JC; Urbancic K; Trubiano JA
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.